THE PHYDRA THESIS
Companies don't fail
because the idea was wrong.
They fail because execution broke.
We acquire them. We turn them around. We exit to strategic buyers at premium multiples. We do this again and again.
Phydra transforms distressed technology companies into revenue-rich acquisition targets.
VC-backed companies not raised since 2023— CB Insights
Investor capital destroyed in 2023 alone— Crunchbase
What distressed B2B tech trades at today — vs. 3x–6x for healthy companies
THE SITUATION
The last decade of funding has created 50,000 stranded companies. Nobody is built to rescue them.
From 2020 to 2022, zero-interest-rate capital funded startups on assumptions that could never survive normal capital costs. When rates moved from 0.25% to 5.50% in 16 months, those assumptions collapsed.
~50,000 VC-backed companies have not raised since 2023. They're not dead — they're stuck. Overcapitalized. Revenue-short. Process-lacking. Founders still in the building.
Traditional PE won't touch them — too small. Search funds can't handle them — too complex. Distressed debt funds want liquidation, not recovery. Venture is built for growth, not rescue.
This is Phydra's market. Exclusively.
“The average distressed technology company still has 60–80% of its product-market fit intact. What's broken is execution — not the idea. That's the unlock. Fix the machine and the value was always there.”
— Phydra Investment Thesis
THE METHOD
A proven plan for turning distress into momentum. Every acquisition, every time.
Stop the bleeding.
Months 1–6
Zombie projects killed. Non-performing staff cut. Every cash leak sealed. 90-day operating cadence installed. Legacy liabilities triaged. The company stops dying and starts stabilizing. Cash visibility and analytics replaces guesswork.
Install the machine.
Months 6–30
Financial rigor replaces guesswork. Systems replace chaos. The revenue engine is rebuilt around the customer who actually pays. The operating team is upgraded. The business learns to run without heroics.
Position for exit.
Months 30–48+
Identify the strategic acquirer before the turnaround completes. Optimize for their metrics. Build the narrative the acquirer needs. Exit at a category peer multiple — not the distressed entry price.
We're not consultants, advisors, or venture investors.
We put our money and time behind your idea.
THE FOUNDER
Dan Waldschmidt has spent 20 years turning around companies for other people. Phydra is the result of decades of lessons learned.
Operational turnaround experience
Across healthcare, SaaS, manufacturing, education, and more
Global operator, not a regional player
Time to exit-quality milestone, in every distressed seat.
“I can sit with a founder and feel their pain. I've failed. I've bled. I know what it feels like to build something and watch it break. It's not about being right. It's about being ruthlessly effective and emotionally intelligent at the same time.”
— Dan Waldschmidt, Founder
Dan is also the author of EDGY Conversations. 700,000+ copies sold.
10th person in history to complete Run Everest.
FOUNDERS
We partner with founders who deserve a second shot.
We work with B2B and consumer-health founders who have real product-market fit but are running out of runway. We bring operating support, capital clarity, and strategic conviction. We pay fairly, move fast, and stay in the building until the job is done.
Tell Us About Your Company →INVESTORS
We turn distress into success at scale.
We buy distressed B2B and consumer-health companies at less than 10% of their last enterprise value, turn them around with a documented operating playbook, and exit to strategic acquirers at recovered multiples. Returns federally tax-free for qualifying taxpayers.
Let's schedule time to talk →THE DISPATCH
Resurgam. I shall rise again.
Great ideas come from great people. And great people need great inspiration.
Resurgam is Phydra's weekly dispatch — all about navigating the messy middle of life. The five things you can control. The mindset required to achieve breakthrough. How to manage forward in spite of it all.
Named for the stone Christopher Wren found in the rubble of St. Paul's Cathedral after the Great Fire of London.